000230 — Ildong Holdings Co Share Price
- KR₩73bn
- KR₩444bn
- KR₩658bn
- 31
- 88
- 33
- 51
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.53 | ||
Price to Tang. Book | 1.56 | ||
Price to Free Cashflow | 41.54 | ||
Price to Sales | 0.11 | ||
EV to EBITDA | 5.11 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 10.36% | ||
Return on Equity | 72.94% | ||
Operating Margin | 7.65% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 596,468.91 | 592,374.55 | 675,539.72 | 638,447.52 | 657,566.89 | n/a | n/a | 17.61% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Ildong Holdings Co., Ltd., formerly Ildong Pharmaceuticals Co., Ltd., is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products mainly include general drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, anti-histamines, antipyretics, analgesics, respiratory medications, endocrine medications, psychoneurological medications, dermatological medications, urologic medications, antibiotics and others. It also provides raw materials, such as synthesises, probiotics and others. In addition, through its subsidiaries, it engages in the advertising agency, medical equipment distribution, software development, food processing and other businesses.
Directors
- Jeong Chi Lee CCH (70)
- Won Yeong Yoon CCH (74)
- Yeon Jin Jung PRE (64)
- Wung Seop Yoon CCE (45)
- Dae Chang Park MDR (62)
- Yong Cheol Kim MDR (64)
- Tae Hyeon Sung MDR (60)
- Yun Jo Hwang OTH (51)
- Gu Seok Jeon OTH (59)
- Jae Hwan Jung OTH (53)
- Jae Hun Kang OTH (55)
- Jung Hyo Kim OTH (58)
- Wan Su Kim OTH (54)
- Byeong An Lee OTH (58)
- Eun Guk Lee OTH (60)
- Jong Sik Lee OTH (71)
- Jeong Seop Park OTH
- Myeong Su Shin OTH (45)
- Jang Hui Won OTH (55)
- Yeong Gil Choi NID (78)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 14th, 1941
- Public Since
- June 28th, 1975
- No. of Shareholders
- 16,087
- No. of Employees
- 1,449
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KSE
- Shares in Issue
- 11,292,090

- Address
- 2, Baumoe-ro 27-gil, Seocho-gu, SEOUL, 06752
- Web
- https://m.ildongholdings.com/
- Phone
- +82 25263114
- Auditors
- Samil Accounting Corporation
Upcoming Events for 000230
Q2 2025 Ildong Holdings Co Ltd Earnings Release
Similar to 000230
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
As of Today at 21:14 UTC, shares in Ildong Holdings Co are trading at KR₩6,320. This share price information is delayed by 15 minutes.
Shares in Ildong Holdings Co last closed at KR₩6,320 and the price had moved by -27.5% over the past 365 days. In terms of relative price strength the Ildong Holdings Co share price has underperformed the FTSE Developed Asia Pacific Index by -26.67% over the past year.
The overall consensus recommendation for Ildong Holdings Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreIldong Holdings Co does not currently pay a dividend.
Ildong Holdings Co does not currently pay a dividend.
Ildong Holdings Co does not currently pay a dividend.
To buy shares in Ildong Holdings Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩6,320, shares in Ildong Holdings Co had a market capitalisation of KR₩73bn.
Here are the trading details for Ildong Holdings Co:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 000230
Based on an overall assessment of its quality, value and momentum Ildong Holdings Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ildong Holdings Co is KR₩20,641. That is 226.59% above the last closing price of KR₩6,320.
Analysts covering Ildong Holdings Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ildong Holdings Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -13.75%.
As of the last closing price of KR₩6,320, shares in Ildong Holdings Co were trading -13.25% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ildong Holdings Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩6,320.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ildong Holdings Co's management team is headed by:
- Jeong Chi Lee - CCH
- Won Yeong Yoon - CCH
- Yeon Jin Jung - PRE
- Wung Seop Yoon - CCE
- Dae Chang Park - MDR
- Yong Cheol Kim - MDR
- Tae Hyeon Sung - MDR
- Yun Jo Hwang - OTH
- Gu Seok Jeon - OTH
- Jae Hwan Jung - OTH
- Jae Hun Kang - OTH
- Jung Hyo Kim - OTH
- Wan Su Kim - OTH
- Byeong An Lee - OTH
- Eun Guk Lee - OTH
- Jong Sik Lee - OTH
- Jeong Seop Park - OTH
- Myeong Su Shin - OTH
- Jang Hui Won - OTH
- Yeong Gil Choi - NID